01 Communique Reports Results for Third Quarter Fiscal 2013
TORONTO, Sept. 5, 2013 /CNW/ - 01 Communique Laboratory Inc. (ONE:TSX) today announced results for its third quarter 2013 which ended July 31, 2013. The loss for the third quarter 2013 was $584,941 compared to $697,693 in 2012 a decrease of $112,852. Excluding non-cash expenses for stock-based compensation and depreciation the adjusted loss for the third quarter 2013 was $235,187 compared to $271,456 in 2012. The Company completed the quarter with $3,566,150 of cash and cash equivalents.
"The cash operating expenses to run our business, excluding the costs associated with intellectual property revenue, were reduced for the third quarter to approximately $400,000," said Andrew Cheung, President and CEO for 01 Communique. "Reducing expenses to this level still allowed us to continue with development of a competitive product offering and continue to vigorously defend our intellectual property rights against LogMeIn Inc. and Citrix Systems Inc. Going forward, we will continue with these two main objectives."
Citrix Litigation Update - On May 8, 2013 a hearing took place in front of the United States Patent and Trademark Office's ("USPTO") Patent Trial and Appeal Board ("PTAB") in respect of the Citrix Systems Inc. ("Citrix") appeal of the results of the inter partes re-examination of our United States patent number 6,928,479 ("'479 Patent") which Citrix had requested. We are now waiting for the PTAB to render their written report. We are confident in the merits of our case and believe the PTAB will uphold the validity of the '479 Patent. Previously the jury in the LogMeIn lawsuit upheld the validity of the 479 Patent as did the USPTO patent examiner in the Right of Appeal Notice ("RAN") and the Examiner's Report filed last year as part of the appeal process.
LogMeIn Appeal Update - We disagree with the jury's finding of non-infringement in the LogMeIn Inc. ("LogMeIn") case and, as previously announced, on June 26, 2013 we filed a notice of appeal with the United States Court of Appeal for the Federal Circuit (Appeal Nos. 2013-1479). LogMeIn has filed a cross appeal, (Case No. 2013-1525) in respect of the Court Order concluding that our patent was valid and enforceable. Their cross appeal has been consolidated with our appeal. As part of the appeal process we filed our Appeal Brief with the Federal Circuit on August 26, 2013. We are confident in the merits of our appeal.
Financial Highlights -
-- Revenue for the third quarter 2013 was $729,860 compared to $582,440 for the same period in 2012, an increase of $147,420 primarily a result of increased revenue from licensing intellectual property. Revenue from intellectual property for the third quarter 2013 was $669,500 (2012 - $500,000). -- Cash operating expenses which exclude stock-based compensation and depreciation were $965,254 for the third quarter 2013 compared to $857,185 in 2012 an increase of $108,069 primarily a result of an increase in expenses relating to intellectual property revenue. -- Excluding expenses related to intellectual property revenue of $568,442 (2012 - $425,000), cash operating expenses for the third quarter 2013 were $396,812 compared to 2012 of $432,185 a reduction of $35,373. The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this release. About 01 Communique Established in 1992, 01 Communique Laboratory Inc. (TSX: ONE) offers a suite of remote access services designed for small-medium sized business, mobile professionals and IT service providers. 01's software as a service offerings are deployed on-demand and include functionality enabling on-line meetings, remote computing and IT support. 01's suite of products includes its remote access offering I'm InTouch (www.imintouch.com), its online meeting offering (www.imintouchmeeting.com) and its remote support offering I'm OnCall (www.imoncall.com ) products are protected in the U.S.A. by its patents #6928479 / #6938076 / #8234701 and in Canada by its patent #2309398 and Japan by its patent #4,875,094. For more information, visit www.01com.com or call (905) 795-888 or (800) 668-2185 (North America only). Cautionary Note Regarding Forward-looking Statements. Certain statements in this news release may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this news release, such statements use such words as "may", "will", "expect", "believe", "plan", "intend", "are confident" and other similar terminology. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this news release. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed under "Risk Factors" in the company's Annual Information Form filed on SEDAR. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the company cannot assure investors that actual results will be consistent with these forward looking statements. These forward-looking statements are made as of the date of this news release, and the company assumes no obligation to update or revise them to reflect new events or circumstances. 01 Communique Laboratory Inc. SELECTED FINANCIAL INFORMATION Consolidated Statements of Financial Position 31-Jul-13 31-Oct-12 Assets Current assets: Cash and cash equivalents $ 3,566,150 $ 4,547,375 Accounts receivable 282,981 41,837 Prepaid expenses and other 35,676 assets 69,080 4,866,032 3,677,067 Property and equipment 17,261 17,961 $ 3,695,028 $ 4,883,293 Liabilities and Shareholders' Equity Current liabilities: Accounts payable and $ 1,117,028 $ 407,770 accrued liabilities Deferred revenue 25,916 34,596 1,142,944 442,366 Shareholders' equity: Share capital 39,997,277 39,566,407 Contributed surplus 4,384,066 3,752,710 Agent options 111,780 248,400 Deficit (41,941,039) (39,126,590) 2,552,084 4,440,927 $ 3,695,028 $ 4,883,293 01 Communique Laboratory Inc. SELECTED FINANCIAL INFORMATION Consolidated Statements of Operations and Comprehensive Income For the 3 and 9 month periods ended July 31, 2013 and 2012 for the 3 months ending for the 9 months ending 31-Jul-13 31-Jul-12 31-Jul-13 31-Jul-12 Revenue $729,860 $582,440 $1,096,299 $753,812 Cost of revenue - 38 - 261 729,860 582,402 1,096,299 753,551 Expenses (income) Selling, 530,394 614,430 1,306,409 general and 1,622,145 administrative Patent 568,442 425,000 1,965,542 enforcement & 425,000 re-examination expenses Research and 216,172 244,092 657,864 development 737,567 Interest (207) (19,067) (3,327) (12,221) 1,314,801 1,280,195 3,910,748 2,772,491 Loss for the (584,941) (697,793) (2,814,449) period and (2,018,940) comprehensive loss Loss per common share Basic $ (0.009) $ $ (0.043) $ (0.012) (0.033) Diluted $ (0.009) $ $ $ (0.012) (0.043) (0.033) Weighted average number of common shares Basic 65,203,807 60,636,502 65,080,948 60,428,803 Diluted 65,203,807 60,636,502 65,080,948 60,428,803 01 Communique Laboratory Inc. SELECTED FINANCIAL INFORMATION Consolidated Statements of Cash Flows For the 3 and 9 month periods ended July 31, 2013 and 2012 three months ending nine months ending 31-Jul-13 31-Jul-12 31-Jul-13 31-Jul-12 Cash provided by (used in): Operating activities: Loss for the $ (584,941) $ (697,793) $ (2,814,449) $ (2,018,940) period Adjustments to reconcile the loss for the period to net cash flows from operating activities: Depreciation 1,538 1,754 5,657 7,099 Stock-based 348,000 925,507 compensation 424,799 631,356 Interest income (207) (3,327) (19,067) (12,221) Change in (217,898) non-cash (1,303) 87,633 908,318 working capital (1,316,453) (236,697) (187,150) (1,288,185) Interest 12,221 income 207 3,327 19,067 received (1,304,232) (236,490) (183,823) (1,269,118) Financing activities: Issue of 375,450 common - 275,450 294,250 shares Investing activities: Purchase of capital (572) (665) (6,357) (1,455) assets Increase 90,962 (930,237) (decrease) (237,062) (981,225) in cash Cash and 3,121,417 cash 3,803,212 2,100,218 4,547,375 equivalents, beginning of period Cash and $ 3,566,150 $ 2,191,180 $ 3,566,150 $ 2,191,180 cash equivalents, end of period
SOURCE 01 Communique Laboratory Inc.
INVESTOR CONTACT: Brian Stringer Chief Financial Officer 01 Communique (905) 795-2888 x204 email@example.com
To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/September2013/05/c4440.html
CO: 01 Communique Laboratory Inc. ST: Ontario NI: CPR ELE SOF ERN
-0- Sep/05/2013 11:30 GMT